BAMF Health Parent, Inc. — SEC Form D Filing

BAMF Health Parent, Inc. filed an SEC Form D on May 19, 2026, reporting $59.65M raised in Health Care.

Form D filing details

Filing
SEC Form D
Filing date
May 19, 2026
Amount reported
$59.65M
Round stage
Series A
Industry
Health Care
Website
https://www.bamfhealth.com/about/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Patients face devastating diseases such as metastatic prostate cancer, for which effective imaging and therapy options may not be widely accessible or affordable.

Solution

BAMF Health provides a vertically integrated platform offering services such as molecular imaging, molecular targeted therapy, radiopharmacy, and participation in clinical trials to improve patient access to precision medicine.

Verdict

Investors backed BAMF Health at this moment because they recognized a compelling need for improved access to imaging and therapy for critical diseases, betting on the urgency of personalized medicine in a market ripe for transformation. This cleared because investors saw an established pain point in patient care accessibility, not because of a clearly defined buyer or budget owner. However, the limited upside lies in the nascent nature of the business’s model and the risk of larger incumbents rapidly overtaking this space with more resources.

Source: SEC EDGAR Form D filing